15-Deoxy-Δ12,14-Prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells

Experimental Cell Research

Volumn 312, Issue 13, 2006, Pages 2538-2546

  Rajasingh, Johnson ^a   Bright, John J ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

ES cell; JAK STAT pathway; LIF signaling; Nuclear receptor; PPAR agonist

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CIGLITAZONE; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; PROTEIN; PROTEIN TYK2; RETINOIC ACID; STAT PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; DRUG DERIVATIVE; INTERLEUKIN 6; JAK1 PROTEIN, HUMAN; JAK1 PROTEIN, MOUSE; JANUS KINASE 1; LIF PROTEIN, HUMAN; LIF PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOTYROSINE; PROSTAGLANDIN D2; PROTEIN KINASE TYK2; PROTEIN TYROSINE KINASE; TYK2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; DOSE RESPONSE; EMBRYONIC STEM CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; EMBRYO; HUMAN; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO; HUMANS; INTERLEUKIN-6; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR; MICE; PHOSPHORYLATION; PHOSPHOTYROSINE; PPAR GAMMA; PROSTAGLANDIN D2; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; TYK2 KINASE;

EID: 33745821610     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.04.010     Document Type: Article

References (59)

1. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotent cells from mouse embryos. Nature 292 (1981) 154-156
2. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 7634-7638
3. Brook F.A., and Gardner R.L. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 5709-5712
4. Graves K.H., and Moreadith R.W. Derivation and characterization of putative pluripotential embryonic stem cells from preimplantation rabbit embryos. Mol. Reprod. Dev. 36 (1993) 424-433
5. Li M., Zhang D., Hou Y., Jiao L., Zheng X., and Wang W.H. Isolation and culture of embryonic stem cells from porcine blastocysts. Mol. Reprod. Dev. 65 (2003) 429-434
6. Thomson J.A., Kalishman J., Golos T.G., Durning M., Harris C.P., Becker R.A., and Hearn J.P. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7844-7848
7. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swtergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147 (Erratum in: Science. 282 (1998) 1827)
8. Doetschman T.C., Eistetter H., Katz M., Schmidt W., and Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87 (1985) 27-45
9. Kawase E., Suemori H., Takahashi N., Okazaki K., Hashimoto K., and Nakatsuji N. Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38 (1994) 385-390
10. Ichikawa Y. Further studies on the differentiation of a cell line of myeloid leukemia. J. Cell. Physiol. 76 (1970) 175-184
11. Smith A.G. Mouse embryo stem cells: their identification, propagation and manipulation. Semin. Cell Biol. 3 (1992) 385-399
12. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.I., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A., and Gough N.M. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336 (1988) 684-687
13. Moreau J.F., Donaldson D.D., Bennett F., Witek-Giannotti J., Clark S.C., and Wong G.G. Leukemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336 (1988) 690-692
14. Smith A.G., and Hooper M.L. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 121 (1987) 1-9
15. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., and Rogers D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336 (1988) 688-690
16. Hibi M., Murakami M., Saito M., Hirano T., Taga T., and Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63 (1990) 1149-1157
17. Gearing D.P., Thut C.J., VandeBos T., Gimpel S.D., Delaney P.B., King J., Price V., Cosman D., and Beckmann M.P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10 (1991) 2839-2848
18. Matsuda T., Nakamura T., Nakao K., Arai T., Katsuki M., Heike T., and Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18 (1999) 4261-4269
19. Sumi T., Fujimoto Y., Nakatsuji N., and Suemori H. STAT3 is dispensable for maintenance of self renewal in nonhuman primate embryonic stem cells. Stem Cells 22 (2004) 861-872
20. Burdon T., Stracey C., Chambers I., Nichols J., and Smith A. Suppression of SHP-2 and ERK signaling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210 (1999) 30-43
21. Blumberg B., and Evans R.M. Orphan nuclear receptors-New ligands and new possibilities. Genes Dev. 12 (1998) 3149-3155
22. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
23. Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M., Moller D.E., and Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun. 224 (1996) 431-437
24. Mukherjee R., Jow L., Croston G.E., and Paterniti Jr. J.R. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272 (1997) 8071-8076
25. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., and Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 4 (1999) 585-595
26. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 (1995) 803-812
27. Lehmann J.M., Moore L.B., Smith O.T., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270 (1995) 12953-12956
28. Shao D., Rangwala S.M., Bailey S.T., Krakow S.L., Reginato M.J., and Lazar M.A. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 396 (1998) 377-380
29. Palmer C.N., Hsu M.H., Griffin H.J., and Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270 (1995) 16114-16121
30. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
31. Tighe A.P., and Gudas L.J. Retinoic acid inhibits leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J. Cell. Physiol. 198 (2004) 223-229
32. Rajasingh J., Raikwar H.P., Muthian G., Johnson C., and Bright J.J. Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem. Biophys. Res. Commun. 340 (2006) 359-368
33. Bright J.J., and Sriram S. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of JAK-2 kinase and prevent experimental allergic encephalomyelitis. J. Immunol. 162 (1999) 6255-6262
34. Burdon T., Smith A., and Savatier P. Signaling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12 (2002) 432-438
35. Raz R., Lee C.K., Cannizzaro L.A., d'Eustachio P., and Levy D.E. Essential role of STAT3 for embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2846-2851
36. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat. Rev., Mol. Cell Biol. 3 (2002) 651-662
37. Boeuf H., Hauss C., and Graeve F.D. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J. Cell Biol. 138 (1997) 1207-1217
38. Niwa H., Burdon T., Chambers I., and Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12 (1998) 2048-2060
39. Ernst M., Gearing D.P., and Dunn A.R. Functional and biochemical association of Hck with LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 13 (1994) 1574-1584
40. Ernst M., Oates A., and Dunn A.R. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J. Biol. Chem. 271 (1996) 30136-30143
41. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., and Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in antiapoptosis. Immunity 5 (1996) 449-460
42. Sheng Z., Knowlton K., Chen J., Hoshijima M., Brown J.H., and Chien K.R. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen activated protein kinase-dependent pathway. J. Biol. Chem. 272 (1997) 5783-5791
43. Minami M., Inoue M., Wei S., Takeda K., Matsumoto M., Kishimoto T., and Akira S. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3963-3966
44. Nakajima K., Yamanaka Y., Nakae K., Kojima H., Ichiba M., Kiuchi N., Kitaoka T., Fukada T., Hibi M., and Hirano T. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15 (1996) 3651-3658
45. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., and Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3801-3804
46. Yamanaka Y., Nakajima K., Fukada T., Hibi M., and Hirano T. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for STAT3 activation. EMBO J. 15 (1996) 1557-1565
47. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., Stahl N., Yancopoulos G.D., and Greenberg M.E. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278 (1997) 477-483
48. Foshay K., Rodriguez G., Hoel B., Narayan J., and Gallicano G.I. JAK2/STAT3 directs cardiomyogenesis within murine embryonic stem cells in vitro. Stem Cells 23 (2005) 530-543
49. Bibel M., Richter J., Schrenk K., Tucker K.L., Staiger V., Korte M., Goetz M., and Barde Y.A. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat. Neurosci. 7 (2004) 1003-1009
50. Okada Y., Shimazaki T., Sobue G., and Okano H. Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Dev. Biol. 275 (2004) 124-142
51. Mao Y., and Lee A.W. A novel role for Gab2 in bFGF-mediated cell survival during retinoic acid-induced neuronal differentiation. J. Cell Biol. 170 (2005) 305-316
52. Murashov A.K., Pak E.S., and Katwa L.C. Parallel development of cardiomyocytes and neurons in embryonic stem cell culture. Biochem. Biophys. Res. Commun. 332 (2005) 653-656
53. Adams M., Montague C.T., Prins J.B., Holder J.C., Smith S.A., Sanders L., Digby J.E., Sewter C.P., Lazar M.A., Chatterjee V.K., and O'Rahilly S. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 100 (1997) 3149-3153
54. Vernochet C., Milstone D.S., Iehle C., Belmonte N., Phillips B., Wdziekonski B., Villageois P., Amri E.Z., O'Donnell P.E., Mortensen R.M., Ailhaud G., and Dani C. PPARgamma-dependent and PPARgamma-independent effects on the development of adipose cells from embryonic stem cells. FEBS Lett. 510 (2002) 94-98
55. Wang C.H., Ciliberti N., Li S.H., Szmitko P.E., Weisel R.D., Fedak P.W., Al-Omran M., Cherng W.J., Li R.K., Stanford W.L., and Verma S. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109 (2004) 1392-1400
56. Nagasawa E., Abe Y., Nishimura J., Yanase T., Nawata H., and Muta K. Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation. Exp. Hematol. 33 (2005) 857-864
57. Lee H.K., Lee B.H., Park S.A., and Kim C.W. The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis. Proteomics 6 (2006) 1223-1229
58. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., and Mortensen R.M. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4 (1999) 611-617
59. Szanto A., and Nagy L. Retinoids potentiate peroxisome proliferator-activated receptor gamma action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells. Mol. Pharmacol. 67 (2005) 1935-1943